Sign in
Impact of repurposed drugs on the symptomatic COVID-19 patients
Journal article   Open access  Peer reviewed

Impact of repurposed drugs on the symptomatic COVID-19 patients

Iqbal Hussain, Afzal Hussain, Mohamed F. Alajmi, Md. Tabish Rehman and Samira Amir
Journal of infection and public health, Vol.14(1), pp.24-38
01/01/2021
PMCID: 7720699
PMID: 33341481

Abstract

Chloroquine COVID-19 Diagnosis Drug toxicities Favipiravir Hydroxychloroquine Lopinavir Precautionary measures Remdesivir Ritonavir SARS-CoV-2 Umifenovir
url
https://doi.org/10.1016/j.jiph.2020.11.009View
Published (Version of record) Open

Metrics

1 Record Views

Details